User:Wilfred J. Poppinga/Notebook/cAMP compartmentalization/2010/02/25: Difference between revisions
From OpenWetWare
m (→Related) |
m (→Results) |
||
Line 83: | Line 83: | ||
===Results=== | ===Results=== | ||
* {{todo| | * {{todo|VASP blot, Anouk}} | ||
* [[User:Wilfred_J._Poppinga/Notebook/cAMP_compartmentalization/2010/02/26#Attachment|Viability staining]] | |||
===Related entries=== | ===Related entries=== | ||
====Run 2: Ht31 Dose/Effect Curve & S<sup>0</sup> D9/D12==== | ====Run 2: Ht31 Dose/Effect Curve & S<sup>0</sup> D9/D12==== |
Revision as of 02:23, 23 March 2010
<html><style type="text/css"> .todo { color: red } .done { color: green} </style></html>
Co-immunoprecipitation part III | <html><img src="/images/9/94/Report.png" border="0" /></html> Main project page <html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html> </html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html> | ||||||||||||
SummaryThe samples have been incubated with the (PKA) antibody coated beads and today the beads are washed and stored in Laemli buffer Materials & MethodsMaterials
MethodCo-immunoprecipitation
VASP
Coating of plate
BSc.
Results
Related entriesRun 2: Ht31 Dose/Effect Curve & S0 D9/D12Same actionRelated topics
|